Drug delivery system in hormonal agents: Long-term release LH-RH agonist

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

Leuprorelin (leuprolide) acetate, a highly active agonist of luteinizing hormone-releasing hormone (LH-RH) has been widely accepted as a representative agent utilizing drug delivery system. A single injection of this one-month or three-month depot provides persistent drug release, which has been applied to therapy in patients with prostate cancer, breast cancer, endometriosis, myoma uteri, and central precocious puberty. The profile of this drug from basic research to clinical application was reviewed. © 2003, THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM. All rights reserved.

Cite

CITATION STYLE

APA

Ohyama, C., & Kato, T. (2003). Drug delivery system in hormonal agents: Long-term release LH-RH agonist. Drug Delivery System, 18(5), 431–437. https://doi.org/10.2745/dds.18.431

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free